CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of...

49
CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta

Transcript of CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of...

Page 1: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.

CT Imaging Issues in the

Critically Ill

E. Wiebe, MD, FRCPCDepartment of Radiology

University of Alberta

Page 2: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.

I have no financial or other disclosures

CT Imaging Issues in the

Critically Ill

Page 3: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.

Imaging Issues and Strategies

Patient selection Region of interest Use of contrast IV contrast Use of oral contrast Contrast risk Radiation risk

Page 4: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.

Imaging Issues and Strategies

Patient selection Clinical findings Prior imaging findings Imaging limitations and access Relative contraindications

Page 5: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.

Imaging Issues and Strategies

Patient selection Region of interest

Clinical findings Mechanism of injury Previous imaging findings

Page 6: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.

Imaging Issues and Strategies

Noncontrast exam Acute retroperitoneal hemorrhage Bone injuries Aortic dissection or rupture

IV Contrast use Vascular injuries and diseases Solid organ assessment Bowel wall assessment

Page 7: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 8: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 9: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 10: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 11: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.

Imaging Issues and Strategies Oral contrast use

Positive contrast (eg. Telebrix or Gastrografin Demonstates bowel leak Impairs bowel wall assessment Variable lumen distention

Negative contrast (eg. Water or Polyethylene

glycol solution) Better assessment of bowel wall Cannot identify bowel leak

Page 12: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 13: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 14: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 15: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 16: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 17: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 18: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 19: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 20: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 21: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 22: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 23: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 24: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 25: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 26: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 27: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 28: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 29: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 30: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 31: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 32: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 33: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 34: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 35: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 36: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 37: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 38: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.
Page 39: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.

Imaging Issues and Strategies

Contrast risk Anaphylactoid reaction Nephrotoxicity

Page 40: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.

Imaging Issues and Strategies Anaphylactoid reaction

Dose and concentration independent Screen patients for increased risk Preventative premedication with

corticosteroids and antihistamines No correlation or association with

shellfish allergy and povidone-iodine

skin cleansing solution

Page 41: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.

Imaging Issues and Strategies Nephrotoxicity

recent meta-analysis suggested that the risk

of contrast-induced nephrotoxicity is less

than previously suggested (Radiology 2010;

256:21–28) Most recent study concludes that there is

increased risk in patients with estimated

GFR of <40ml/min (Radiology 2013:

268:719-28)

Page 42: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.

Imaging Issues and Strategies Nephrotoxicity

Dose dependent Intravenous hydration is most important

preventative measure Consider benefit of noncontrast scan

Page 43: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.

Imaging Issues and Strategies

Radiation dose and risk Main concern is induction of cancer ALARA principle Recognize the relative risk of CT and

radiography Use technology advances made to

decrease dose

Page 44: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.

Imaging Issues and Strategies

Radiation dose Measured as effective dose in mSV Background radiation dose: 3mSv/yr Standard CT abdomen dose: 8-10mSv

for single scan Low dose exams decrease dose to 2-

4mSv/scan

Page 45: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.

Imaging Issues and Strategies Radiation dose

Dose estimate based on dose-length

product (DLP) which is given with each

scan Chest CT dose = 0.017 x DLP Abdomen CT dose = 0.015 x DLP Head CT dose = 0.023 x DLP Neck CT dose = 0.059 x DLP

Page 46: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.

625 x 0.015 = 9.37 mSv659 x 0.015 = 9.88 mSv630 x 0.015 = 9.45 mSv

Total effective dose = 28.7 mSv

Imaging Issues and Strategies

Page 47: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.

Total effective dose = 166 x 0.017 = 2.82 mSv

Imaging Issues and Strategies

Page 48: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.

Imaging Issues and Strategies

Tailor exam to clinical situation Use intravenous and oral contrast

when necessary but not always Be aware of risks of imaging

Page 49: CT Imaging Issues in the Critically Ill E. Wiebe, MD, FRCPC Department of Radiology University of Alberta.

Questions?